Hi,everyone
i had some trouble when running NovelSeq(http://compbio.cs.sfu.ca/novelseq/manual.html). As we know, NovelSeq is a pepiline that was designed to detect novel sequence insertions using paired-end next-generation sequencing. In my project, i am in trouble when running novel_cluster. Before running the novel_cluster program, i had mapped the illumina pair-end reads (42X72bp) to the O.sativa_japonica genome using mrfast, and got the output files including: OEA alignment file (SAM), unmapped reads(Orphan) (fastq) and the OEA sequences fasta file. Then i assemblied the Orphan reads into contigs by using the ABySS package. Following the manual of NovelSeq, now i must cluster the OEA reads and localy assembly the OEA clusters using novelseq_cluster program, i prepared all the input files needed for novelseq_cluster, then running..., unluckly, it shows some errors, i also checked the input files again, and didn't find any error. Un..
who can give me some advices? Great appreciate for your any kind help!
the error info is as below:
------------------------
xiaenhua@node69: ~/Alignment_Tools/novelseq-upload/novel_cluster /home/xiaenhua/Novel_Seq/gla/3_OEACluster/novelseq-upload/ ../gla_OEA.sam ../satRemChrs.txt ../Chr_length/ ../gla_OEA.fa ../histogram.txt 100
./parserQualWReadPrunWSatellite /home/xiaenhua/Novel_Seq/gla/3_OEACluster/novelseq-upload//../gla_OEA.sam /home/xiaenhua/Novel_Seq/gla/3_OEACluster/novelseq-upload//../satRemChrs.txt > ../gla_OEA.sam.parsed
cut -f1 ../gla_OEA.sam.parsed > ../gla_OEA.sam.Name
./unique ../gla_OEA.sam.Name > ../gla_OEA.sam.Name.Unique
./sortString ../gla_OEA.sam.Name.Unique > ../gla_OEA.sam.Name.Unique.sort
cut -f1,6,8 ../gla_OEA.sam.parsed > ../gla_OEA.sam.Name.Edit.Prob
./calProbMinEditRead ../gla_OEA.sam.Name.Unique.sort ../gla_OEA.sam.Name.Edit.Prob > ../gla_OEA.sam.Name.MinEdit.TotalProb
sh: line 1: 20325 Segmentation fault ./calProbMinEditRead ../gla_OEA.sam.Name.Unique.sort ../gla_OEA.sam.Name.Edit.Prob >../gla_OEA.sam.Name.MinEdit.TotalProb
./convertToInvLRProbMinEditDist ../gla_OEA.sam.parsed $dataset.Name.MinEdit.TotalProb > ../gla_OEA.sam.parsed.LR
sh: line 1: 20327 Segmentation fault ./convertToInvLRProbMinEditDist ../gla_OEA.sam.parsed $dataset.Name.MinEdit.TotalProb >../gla_OEA.sam.parsed.LR
./OEASetsProb ../Chr_length//chroName1 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr1
./OEASetsProb ../Chr_length//chroName2 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr2
./OEASetsProb ../Chr_length//chroName3 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr3
./OEASetsProb ../Chr_length//chroName4 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr4
./OEASetsProb ../Chr_length//chroName5 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr5
./OEASetsProb ../Chr_length//chroName6 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr6
./OEASetsProb ../Chr_length//chroName7 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr7
./OEASetsProb ../Chr_length//chroName8 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr8
./OEASetsProb ../Chr_length//chroName9 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr9
./OEASetsProb ../Chr_length//chroName10 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr10
./OEASetsProb ../Chr_length//chroName11 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr11
./OEASetsProb ../Chr_length//chroName12 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr12
./OEASetsProb ../Chr_length//chroName13 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr13
./OEASetsProb ../Chr_length//chroName14 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr14
./OEASetsProb ../Chr_length//chroName15 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr15
./OEASetsProb ../Chr_length//chroName16 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr16
./OEASetsProb ../Chr_length//chroName17 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr17
./OEASetsProb ../Chr_length//chroName18 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr18
./OEASetsProb ../Chr_length//chroName19 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr19
./OEASetsProb ../Chr_length//chroName20 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr20
./OEASetsProb ../Chr_length//chroName21 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr21
./OEASetsProb ../Chr_length//chroName22 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr22
./OEASetsProb ../Chr_length//chroName23 ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chr23
./OEASetsProb ../Chr_length//chroNameX ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chrX
./OEASetsProb ../Chr_length//chroNameY ../gla_OEA.sam.parsed.LR ../gla_OEA.sam.parsed.chrY
cat ../gla_OEA.sam.parsed.chr? >> ../gla_OEA.sam.parsed.AllChr
cat ../gla_OEA.sam.parsed.chr?? >> ../gla_OEA.sam.parsed.AllChr
./setCoverProbWeighted ../gla_OEA.sam.Name.Unique.sort ../gla_OEA.sam.parsed.AllChr
./type1to2convertor ../gla_OEA.sam.parsed.AllChr ../gla_OEA.fa
sh: ./fs-fa.out: No such file or directory
./oea.LocalAssembly ../histogram.txt ../gla_OEA.sam.parsed.AllChr.type2 100
sh: ./oea.LocalAssembly: No such file or directory
--------------------
Note:my working dir is :
/home/xiaenhua/Novel_Seq/gla/3_OEACluster/novelseq-upload/
(the same as NovelSeq Install dir)
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
Latest Articles
Collapse
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
-
by seqadmin
Sequencing mRNA provides a snapshot of cellular activity, allowing researchers to study the dynamics of cellular processes, compare gene expression across different tissue types, and gain insights into the mechanisms of complex diseases. “mRNA’s central role in the dogma of molecular biology makes it a logical and relevant focus for transcriptomic studies,” stated Sebastian Aguilar Pierlé, Ph.D., Application Development Lead at Inorevia. “One of the major hurdles for...-
Channel: Articles
08-07-2024, 12:11 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 08-27-2024, 04:40 AM
|
0 responses
16 views
0 likes
|
Last Post
by seqadmin
08-27-2024, 04:40 AM
|
||
New Single-Molecule Sequencing Platform Introduces Advanced Features for High-Throughput Genomics
by seqadmin
Started by seqadmin, 08-22-2024, 05:00 AM
|
0 responses
293 views
0 likes
|
Last Post
by seqadmin
08-22-2024, 05:00 AM
|
||
Started by seqadmin, 08-21-2024, 10:49 AM
|
0 responses
135 views
0 likes
|
Last Post
by seqadmin
08-21-2024, 10:49 AM
|
||
Started by seqadmin, 08-19-2024, 05:12 AM
|
0 responses
124 views
0 likes
|
Last Post
by seqadmin
08-19-2024, 05:12 AM
|